Interpreting Steep Dose-Response Curves in Early Inhibitor Discovery

Brian K. Shoichet
Department of Pharmaceutical Chemistry, University of CaliforniaSan Francisco, 1700 4th Street, San Francisco, California 94158
J. Med. Chem., 2006, 49 (25), pp 7274–7277
DOI: 10.1021/jm061103g
Publication Date (Web): November 10, 2006
Copyright © 2006 American Chemical Society

 Phone:  415-514-4126. Fax:  415-514-4260. E-mail:  shoichet@ cgl.ucsf.edu.

Abstract

Abstract Image

Many screening hits inhibit enzymes with steep dose-response curves, which are considered pathological. Three models might explain these curves:  multisite binding, an inhibitor phase transition, or stoichiometric inhibition caused by a high enzyme to Kd ratio. Experiments with promiscuous aggregators, for which steep curves are common, suggest that these curves owe to stoichiometric inhibition, which predicts that IC50 should vary linearly with enzyme concentration. Most steep dose-response curves in screening may be due to this effect.

Tools

History

  • Published In Issue December 14, 2006
  • Received September 21, 2006

Recommend & Share

Related Content

Other ACS content by these authors: